![](https://www.ccamp.res.in/sites/default/files/styles/medium/public/Anandkumar_1.jpg?itok=s0yrPWJd)
Dr. Anand Anandkumar is the Co-founder of Bugworks Research a drug discovery company that aims to discover novel treatment options for resistant bacterial infections. Bugworks is a spin-off from Cellworks, a therapeutic design company using proprietary simulation technology and he serves as an External Director and Chairman of the Board of Directors of the India operations of Cellworks.Anandkumar received his MS and PhD in Biomedical & Electrical Engineering from George Washington University, Washington DC. He is a veteran of the Semiconductor Industry with more than 18 years of experience, specializing in Electronic Design Automation (EDA) Software products, IC design and in setting up and running global operations in Emerging markets India and China. Before co-founding Bugworks, Anandkumar was the founding Managing Director of the India operations of Magma Design Automation, where he was responsible for setting up and driving many aspects of the Operations including RD, Product Engineering, Business Development and links to Government/Academia. The India operation of Magma which Anandkumar founded in 2003 is Magma's largest subsidiary with roughly 25% of the worldwide headcount.